| Code | 3701C | ||||||||||
| MA number | 21/0120/17-S | ||||||||||
| Product Form: | cps dur 56x300 mg (blis.PVC/PVDC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Egis Pharmaceuticals PLC, Hungary | ||||||||||
| Therapeutic Class: | 21 - ANTIEPILEPTICA, ANTICONVULSIVA | ||||||||||
| ATC: | 
                
  | 
        ||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use | 
| Prescription Status: | Medicinal product subject to medical prescription. | 
| Legal basis: | Article 10(1) generic application | 
| MA issued: | 27.04.2017 | 
| PIL: | 
            
                 | 
    
| SPC: | 
            
                 | 
    
| Safety feature | Yes | 
| Data update: | 26.07.2024 |